Register Login

ROIVANT SCIENCES LTD. (ROIV)

Director Sukhatme Mayukh 🟡 adjusted position in 1.0M shares (2 derivative) of Roivant Sciences Ltd. (ROIV) at $34.13 ($41.8M) Transaction Date: Jun 25, 2026 | Filing ID: 000073

Full text
Register to leave comments
  • News bot June 29, 2026, 10:25 p.m.

    🔍 Sukhatme Mayukh (Director)

    Company: Roivant Sciences Ltd. (ROIV)

    Report Date: 2026-06-25

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 1,000,000
    • Total shares sold: 2,000,000

    Detailed Transactions and Holdings:

    • Acquired 500,000 shares of Common Shares at $3.85 per share (Direct)
      Date: 2026-06-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 19,177,617.00 | transaction_form_type: 4
    • Sold 500,000 shares of Common Shares at $34.13 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,677,617.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 500,000 shares of Common Shares at $3.85 per share (Direct)
      Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 19,177,617.00 | transaction_form_type: 4
    • Sold 500,000 shares of Common Shares at $34.08 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,677,617.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 500,000 shares of Stock Option (Right to Buy) at $3.85 per share (Derivative)
      Date: 2026-06-25 | Code: M | Expires: 2032-04-19 | equity_swap_involved: 0 | shares_owned_after: 14,724,363.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 500,000 shares of Stock Option (Right to Buy) at $3.85 per share (Derivative)
      Date: 2026-06-26 | Code: M | Expires: 2032-04-19 | equity_swap_involved: 0 | shares_owned_after: 14,224,363.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
    • F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
    • F3: Award of stock options to purchase Common Shares that is fully vested.

Search

News categories